Even a decade in, the Affordable Care Act’s recommendations to simply cover preventive screening and care without cost sharing remain confusing and complex.
New government rules force health insurers to publicly disclose what they pay for just about every service. That information could help consumers and employers know whether they’re getting a fair deal.
Plenity está aprobado por la FDA como un dispositivo que contiene granos de un hidrogel absorbente de origen vegetal. Cada grano se “infla” hasta 100 veces su tamaño, llenando una cuarta parte del estómago de una persona.
Approved as a device, not a drug, Plenity contains a plant-based gel that swells to fill 25% of a person’s stomach, to help people eat less. Results vary widely but are modest on average.
The nation’s largest supplier of platelets is moving to a method it says is easier for hospitals, but one that sharply raises costs, leading some centers to demand more options.
Dictionaries, public comments, and even an old court case that involved underwear pricing could play a role as the government appeals a ruling that sharply limits federal authority during pandemics.
A recent court decision that overturns one of the Centers for Disease Control and Prevention’s few pandemic rules — masks required on public transportation — spotlights how little power remains in federal hands to enforce public health protections.
The Biden administration unveiled a new special enrollment option aimed at signing up low-income Americans for Affordable Care Act coverage — even if it is outside of the usual annual open enrollment period. But insurers are cutting broker commissions at the same time.
Diagnosed with aggressive leukemia on a Western trip, a young man thought his insurance would cover an air ambulance ride home to North Carolina. Instead, questions about medical necessity left him with an astronomical bill.
Some practitioners object to the way upfront cost estimates are designed, saying they could affect access to care and are burdensome. Other experts disagree.
The Department of Health and Human Services issued preliminary rules regarding health insurance marketplaces that aim to deter fraudulent sign-ups for coverage. Experts say the agency’s action indicates a problem exists.
Muchos ven a los kits caseros negativos como una “tarjeta de libertad”. Pero puede haber errores, y también infecciones futuras.
Although at-home antigen testing remains a useful tool, experts warn it is often used inappropriately and can provide false confidence for people concerned about safety.
The American Medical Association and American Hospital Association are not arguing to halt the law that protects patients from unexpected bills from providers they didn’t know were outside their insurance network. Instead, they want to change the rules for the mediators who will settle the dispute between insurers and providers.
Medicare billing codes for audio-only follow-up check-ins lead to new reimbursement battles.
The Community Oncology Alliance is targeting the prescription drug provisions of the Build Back Better Act, saying they will trigger deep cuts in oncologists’ pay, causing clinics to close and health care costs to rise. But it leaves out some important details.
Fueled by consumer frustration with high premiums and deductibles, two new offerings promise a means for consumers to take control of their health care costs. But experts say they pose risks.
¿Lo esencial? Vacunarse con cualquiera de las tres vacunas disponibles en los Estados Unidos disminuye la posibilidad de infectarse en primer lugar y reduce de manera significativa el riesgo de hospitalización o muerte si se contrae el coronavirus y se desarrolla covid-19.
Reports of waning effectiveness and mixed messages about booster shots fuel the politicization of vaccination.
New, often lower-cost plans capitalize on the convenience of telemedicine — and patients’ growing familiarity with it. But consumers should weigh costs and care options before enrolling in a “virtual-first” plan.